Literature DB >> 6781094

Acquired von Willebrand's syndrome in the course of Waldenström's disease.

C Mazurier, A Parquet-Gernez, J Descamps, F Bauters, M Goudemand.   

Abstract

Acquired von Willebrand's syndrome with a regressive evolution is described in a 66 year old man with Waldenström's disease. An inhibitor electively directed against Ristocetin cofactor activity has been demonstrated, active in vitro after incubation at 37 degrees C. Serum fractionation showed that the inhibitor was independent of the monoclonal IgM and subsequent purification that it was IgG in nature. The results permit its classification as an auto-antibody.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6781094

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Acquired von Willebrand syndrome in a 10-year-old girl with acute lymphoblastic leukaemia.

Authors:  Isabel Dorn; Ulrich Budde; Michael C Frühwald; Monika Pöppelmann; Ulrike Nowak-Göttl
Journal:  BMJ Case Rep       Date:  2009-06-21

Review 2.  Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management.

Authors:  Hiroshi Mohri
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

3.  Retroperitoneal haemorrhage with abscess formation complicating Waldenström's macroglobulinaemia.

Authors:  R Bohus; W C Waltzer; Z Frischer; M Gonder
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

Review 4.  The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer.

Authors:  Chanukya K Colonne; Emmanuel J Favaloro; Leonardo Pasalic
Journal:  Healthcare (Basel)       Date:  2022-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.